Metabolomics study of esophageal adenocarcinoma

Journal of Thoracic and Cardiovascular Surgery

Volumn 141, Issue 2, 2011, Pages 469-475.e4

  Zhang, Jian ^a   Liu, Lingyan ^b   Wei, Siwei ^a   Nagana Gowda, G A ^a   Hammoud, Zane ^c   Kesler, Kenneth A ^d   Raftery, Daniel ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; BIOLOGICAL MARKER; CITRIC ACID; CREATININE; GLUCOSE; GLUTAMINE; LACTIC ACID; LYSINE; TRICHLOROACETIC ACID;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOCHEMISTRY; BLOOD SAMPLING; CANCER PATIENT; CANCER SCREENING; CONTROLLED STUDY; DYSPLASIA; EARLY DIAGNOSIS; ENERGY METABOLISM; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLITE; METABOLOMICS; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; TRAINING;

EID: 78751579001     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.08.025     Document Type: Article

References (27)

1. R.T. Greenlee, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 2000 CA Cancer J Clin 50 2000 7 33
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
3. M.F. Reed, G. Tolis Jr., B.H. Edil, J.S. Allan, D.M. Donahue, and H.A. Gaissert Surgical treatment of esophageal high-grade dysplasia Ann Thorac Surg 79 2005 1110 1115
4. I. Waxman, G.S. Raju, J. Critchlow, D.A. Antonioli, and S.J. Spechler High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series Am J Gastroenterol 101 2006 1773 1779
5. N.J. Shaheen, and J.E. Richter Barrett's oesophagus Lancet 373 2009 850 861
6. G.A. Prasad, K.K. Wang, K.C. Halling, N.S. Buttar, L.M. Wongkeesong, and A.R. Zinsmeister Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus Gastroenterology 135 2008 370 379
7. M. Javle, S. Ailawadhi, G.Y. Yang, C.E. Nwogu, M.D. Schiff, and H.R. Nava Palliation of malignant dysphagia in esophageal cancer: a literature-based review J Support Oncol 4 2006 365 373 79
8. J.W. van Baal, and K.K. Krishnadath High throughput techniques for characterizing the expression profile of Barrett's esophagus Dis Esophagus 21 2008 634 640
9. J.W. van Baal, A.M. Rygiel, F. Milano, M. Anderson, J.J. Bergman, and C.A. Spek Gene expression profile comparison of Barrett's esophagus epithelial cell cultures and biopsies Dis Esophagus 21 2008 628 633
10. J.K. Nicholson, J.C. Lindon, and E. Holmes "Metabonomics": understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 1999 1181 1189
11. G.A. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, and D. Raftery Metabolomics-based methods for early disease diagnostics Expert Rev Mol Diagn 8 2008 617 633
12. Z. Pan, and D. Raftery Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics Anal Bioanal Chem 387 2007 525 527
13. A. Sreekumar, L.M. Poisson, T.M. Rajendiran, A.P. Khan, Q. Cao, and J. Yu Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 12 2009 910 914
14. H. Wu, R. Xue, C. Lu, C. Deng, T. Liu, and H. Zeng Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 877 2009 3111 3117
15. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J Roy Stat Soc.B 57 1995 289 300
16. J.K. Nicholson, P.J. Foxall, M. Spraul, R.D. Farrant, and J.C. Lindon 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma Anal Chem 67 1995 793 811
17. O. Warburg, K. Posener, and E. Negelein On the metabolism of carcinoma cells Biochemische Zeitschrift 152 1924 309 344
18. K. Odunsi, R.M. Wollman, C.B. Ambrosone, A. Hutson, S.E. McCann, and J. Tammela Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics Int J Cancer 113 2005 782 788
19. S. Walenta, M. Wetterling, M. Lehrke, G. Schwickert, K. Sundfor, and E.K. Rofstad High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers Cancer Res 60 2000 916 921
20. Y. Qiu, G. Cai, M. Su, T. Chen, X. Zheng, and Y. Xu Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS J Proteome Res 8 2009 4844 4850
21. S. Walenta, T. Schroeder, and W. Mueller-Klieser Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology Curr Med Chem 11 2004 2195 2204
22. M. Rantalainen, O. Cloarec, O. Beckonert, I.D. Wilson, D. Jackson, and R. Tonge Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice J Proteome Res 5 2006 2642 2655
23. M.J. Tisdale Cancer cachexia: metabolic alterations and clinical manifestations Nutrition 13 1997 1 7
24. Y. Yang, C. Li, X. Nie, X. Feng, W. Chen, and Y. Yue Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis J Proteome Res 6 2007 2605 2614
25. L. Bianchi, E. De Micheli, A. Bricolo, C. Ballini, M. Fattori, and C. Venturi Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study Neurochem Res 29 2004 325 334
26. C. Denkert, J. Budczies, W. Weichert, G. Wohlgemuth, M. Scholz, and T. Kind Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover Mol Cancer 7 2008 72
27. S. Tiziani, V. Lopes, and U.L. Gunther Early stage diagnosis of oral cancer using 1H NMR-based metabolomics Neoplasia 11 2009 269 276